$105.62 Nov 18, 2026 · market cap $61.9B
Edwards Lifesciences trades at $106. Our three models put it at $46–$56 (base $47): above all three.
Cash Flow $56 · Buffett $47 · Damodaran $46 · models run Nov 18, 2026
12 of 121 tracked investors hold it · Q3 2026 13F filings
Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app